Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aveir DR Real-World Evidence Post-Approval Study

NCT: NCT05935007 · RECRUITING

NCT IDNCT05935007
StatusRECRUITING
Start Date2023-10-31
Completion2030-12-31

Brief Summary

The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.

Frequently Asked Questions

What is Aveir DR Real-World Evidence Post-Approval Study?

Aveir DR Real-World Evidence Post-Approval Study is a clinical trial registered under NCT05935007. Current status: RECRUITING.

What is the status of NCT05935007?

The current status of NCT05935007 (Aveir DR Real-World Evidence Post-Approval Study) is: RECRUITING.

When did Aveir DR Real-World Evidence Post-Approval Study start?

Aveir DR Real-World Evidence Post-Approval Study started on 2023-10-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.